Reinstating LDL-C Targets

Panelists discuss how reinstating low-density lipoprotein cholesterol (LDL-C) targets could realign quality programs toward outcomes-driven care. Setting measurable goals encourages clinicians to intensify therapy and monitor progress.

They emphasize that outcomes-based incentives could harmonize payer and provider priorities, fostering accountability across systems. Restoring LDL-C targets may also reduce variability and close treatment gaps by making success measurable.

The discussion underscores that combining statin adherence metrics with LDL-C goal attainment could produce the most balanced and impactful framework.